Publications by authors named "Holly A Read"

Claim this Profile
C
Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial.
Walter Reinisch, Jean-Frédéric Colombel, Geert D'Haens, William J Sandborn, Paul Rutgeerts, Holly A Read

J Crohns Colitis· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder.
Mark E Bangs, Ling Jin, Shuyu Zhang, Durisala Desaiah, Albert J Allen, Holly A Read

Drug Saf· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.
David Michelson, Holly A Read, Dustin D Ruff, Jennifer Witcher, Shuyu Zhang

J Am Acad Child Adolesc Psychiatry· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemodynamic effects of acute administration of atomoxetine and methylphenidate.
Ronan P Kelly, Kwee Poo Yeo, Choo-Hua Teng, Brian P Smith, Stephen Lowe, Holly A Read

J Clin Pharmacol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome.
John-Michael Sauer, Amanda J Long, Barbara Ring, Jennifer S Gillespie, Nathan P Sanburn, Holly A Read

J Pharmacol Exp Ther· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical risk management: a call to arms for pharmacoepidemiology.
David L Hyslop, Holly A Read, Daniel N Masica, James G Kotsanos

Pharmacoepidemiol Drug Saf· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis